FLT3+ DC inhibits immune rejection via interaction with Treg in liver transplantation.

MLA

Zhang, Jin-Ming, et al. “FLT3+ DC Inhibits Immune Rejection via Interaction with Treg in Liver Transplantation.” International Immunopharmacology, vol. 137, Aug. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.intimp.2024.112289.

APA

Zhang, J.-M., Huang, H., Li, X.-Q., Li, S.-P., Zhou, L.-X., Song, S.-Y., & Zhu, Z.-J. (2024). FLT3+ DC inhibits immune rejection via interaction with Treg in liver transplantation. International Immunopharmacology, 137, N.PAG. https://doi.org/10.1016/j.intimp.2024.112289

Chicago

Zhang, Jin-Ming, Hao Huang, Xin-Qiang Li, Shi-Peng Li, Liu-Xin Zhou, Si-Yuan Song, and Zhi-Jun Zhu. 2024. “FLT3+ DC Inhibits Immune Rejection via Interaction with Treg in Liver Transplantation.” International Immunopharmacology 137 (August): N.PAG. doi:10.1016/j.intimp.2024.112289.